Science to transform lives

Immunocore is a pioneering, commercial-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease

About us

Our science

We have a robust pipeline of wholly owned and partnered programmes to address a broad spectrum of disease indications.

Pipeline
Publications
Scientific Advisory Board

Our focus

Our foundation is built on our proprietary soluble TCR bi-specific ImmTAC® platform.

Oncology
Infectious Diseases
Autoimmune and Inflammation Diseases

Clinical trials

Clinical trials are an important part of helping to bring safe and effective medicines to patients. We have a number of clinical trials currently recruiting.